TransEnterix (TRXC) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Goldman warns high investor conviction could amplify volatility as sentiment shift
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Microsoft pulls out of UK data center deal with Nscale, Telegraph reports
- Lithuanians forced to take shelter after suspected drone enters airspace
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
TransEnterix, Inc. Reports Operating Results for the Second Quarter 2016
August 5, 2016 6:55 AM EDTRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the second quarter of 2016.
ALF-X Commercial Update
On July 29, 2016, the Company closed its first sale of the ALF-X® Surgical Robotic System to Humanitas Hospital, a highly-specialized research and teaching hospital partnered with Humanitas University Medical School, located in Milan, Italy.
"We are very pleased with the progress weve made in the... More



